Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Gene Transfer Therapy Study to Evaluate the Safety of SRP-9001 in Participants With Duchenne Muscular Dystrophy (DMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03375164
Recruitment Status : Active, not recruiting
First Posted : December 15, 2017
Last Update Posted : February 25, 2022
Information provided by (Responsible Party):
Sarepta Therapeutics, Inc.